Plus   Neg

Gilead Reports Encouraging Data From Remdesivir 5-day Treatment Course

Gilead Sciences, Inc. (GILD) said the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia showed that patients in the 5-day remdesivir treatment group were 65 percent more likely to have clinical improvement at day 11 compared with those in the standard of care group. For the 10-day treatment group also, results were favorable, trending toward but not reaching statistical significance, the company noted. No new safety signals were identified.

"We now have three randomized, controlled clinical trials demonstrating that remdesivir improved clinical outcomes by several different measures. Today's results showed that when treating moderate disease, a 5-day course of remdesivir led to greater clinical improvement than standard of care," said Merdad Parsey, Chief Medical Officer, Gilead Sciences, said.

Remdesivir is currently approved in Japan as a treatment for patients with SARS-CoV-2. Outside of Japan, remdesivir is an investigational drug.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
U.S. Bancorp (USB) reported second quarter earnings per share of $0.41, compared to $1.09, a year ago. On average, 22 analysts polled by Thomson Reuters expected the company to report profit per share of $0.22, for the quarter. Analysts' estimates typically exclude special items. Net income attributable... Flagstone Foods LLC is recalling certain Wegmans Pecan Blend Trail Mix citing the possible presence of undeclared almonds and walnuts, the U.S. Food and Drug Administration announced. The Robersonville, North Carolina-based company initiated the recall following a notification from a customer that the product contained almonds and walnuts that are not listed in the ingredient statement on the pack Ford has revived the iconic Bronco brand after a gap of 24 years, this time as a dedicated off-road brand aiming to take on Fiat Chrysler's Jeep Wrangler, the dominant vehicle in the off-road category. Ford has introduced three new vehicles under the all-new Bronco brand as a 4x4 family of rugged SUVs under the tagline, "Built Wild".
Follow RTT